SecBot SecBot
PRESS-RELEASE ·Filed Mar 19, 2026

EVAX

Evaxion
NEUTRAL
Impact 2/10
Horizonimmediate Processed8mo ago WireGlobeNewswire
Press release · Announcement
Actionable Insight • Neutral

No immediate trading implications. Traders should monitor for any unexpected disclosures during or after the AGM, though such events are typically routine for clinical-stage biotechs like Evaxion.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$4.00
T+0 close · Mar 19, 2026 · via day close
Latest settled
−10.00%
T+60 · $3.60
Vs SPY
−24.34%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 19 $4.00entry
  2. T+1 · 8mo ago −2.25%α −0.51% · $3.91
  3. T+5 · 8mo ago −10.25%α −8.04% · $3.59
  4. T+20 · 7mo ago +11.25%α +3.63% · $4.45
  5. T+60 · 5mo ago −10.00%α −24.34% · $3.60
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Evaxion announced the convening of its Annual General Meeting on April 16, 2026, to be held at its headquarters in Denmark. The filing contains no material financial updates or operational developments, only administrative details about the meeting.

Key Facts

  • Annual General Meeting scheduled for April 16, 2026, at 14:00 CET
  • Meeting to be held at Evaxion's offices in Hørsholm, Denmark
  • Agenda and proposals available on the company’s investor relations website
  • No financial results, guidance, or material corporate updates disclosed

Financial Impact

No financial impact disclosed

Risk Factors

  • Lack of near-term catalysts; company remains in clinical development with no commercial revenue
  • Forward-looking statements highlight risks around funding, clinical trial success, and market acceptance

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3259026

Track record

50 reports on EVAX

Performance horizon

7 of 11 bullish or bearish reports moved the stock their way by T+1. Best: +22.94% at T+5 after the Mar 5, 2026 report. 10 of 11 went positive at some point.

Filters
  1. Nov 12, 20264d ago 6-K Neutral 2/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  2. Nov 12, 20264d ago Press Release Neutral 1/10 Entry $2.77 to $2.74 Now $2.77 −0.00% ▼ −1.08% −0.72% vs SPY
  3. Nov 9, 20267d ago 6-K / F-1/A / PRESS-RELEASE Neutral 3/10 Entry $2.75 to $2.86 Now $2.77 +0.73% ▲ +4.00% +4.37% vs SPY
  4. Nov 6, 202610d ago 6-K Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  5. Nov 6, 202610d ago Press Release Neutral 4/10 Entry $3.00 to $2.75 Now $2.77 −7.67% ▼ −8.33% −10.70% vs SPY
  6. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  7. Nov 4, 202612d ago 6-K Neutral 3/10 Entry $2.97 to $2.76 Now $2.77 −6.73% ▼ −7.07% −2.66% vs SPY
  8. Nov 3, 202613d ago 6-K Neutral 4/10 Entry $2.96 to $2.97 Now $2.77 −6.42% ▲ +0.34% −1.31% vs SPY
  9. Oct 30, 202617d ago 6-K Neutral 2/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
  10. Oct 30, 202617d ago Press Release Neutral 3/10 Entry $2.93 to $2.92 Now $2.77 −5.46% ▼ −0.34% +0.14% vs SPY
Showing 10 of 50

US Market Status

Market Closed · Opens in 6h 40m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 19, 2026